Koss Olinger Consulting, LLC Pro Phase Labs, Inc. Transaction History

Koss Olinger Consulting, LLC

  • $1.14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023
BUY
$4.23 - $7.53 $71,580 - $127,422
16,922 Added 67.26%
42,081 $183,000
Q2 2023

Jul 28, 2023
BUY
$7.15 - $9.78 $29,979 - $41,007
4,193 Added 20.0%
25,159 $182,000
Q1 2023

May 12, 2023
BUY
$6.62 - $9.57 $7,507 - $10,852
1,134 Added 5.72%
20,966 $159,000
Q4 2022

Feb 13, 2023
BUY
$8.78 - $12.47 $174,124 - $247,305
19,832 New
19,832 $190,000

Others Institutions Holding PRPH

# of Institutions
27
Shares Held
1.71M
Call Options Held
0
Put Options Held
0
View Full List

About ProPhase Labs, Inc.

PRPH Quotes by TradingView
  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.1M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email